We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • April 22, 2019

    J&J And Colgate Face Latest Talc Trial Together In Calif.

    Asbestos hidden for decades in talcum powder products made by Johnson & Johnson and Colgate-Palmolive gave a 61-year-old woman mesothelioma, leaving her only months to live, her attorney told a California jury Monday on the first day of trial. 

  • April 22, 2019

    Feds Seek Pause Of SEC's Civil Suit Against Theranos Official

    The government has urged a California federal court to pause a civil suit against a former Theranos Inc. executive amid related pending criminal proceedings in which the ex-leader of the wannabe bloodwork disruptor faces charges over some of the same conduct.

  • April 22, 2019

    J&J Settles Wash. AG's Pelvic Mesh Case Just Before Trial

    Johnson & Johnson has agreed to pay $9.9 million to settle the state of Washington’s allegations that its Ethicon subsidiary downplayed the risks of its surgical mesh devices in its marketing, avoiding a Seattle trial that was about to begin Monday.

  • April 22, 2019

    Aveo Pharma Stock-Drop Suit Lands In Massachusetts

    A proposed class action accusing embattled Aveo Pharmaceuticals Inc., its CEO and two others of misleading investors ahead of a sharp January stock drop was moved to Massachusetts federal court Monday after the company's unopposed bid to transfer the suit from New York.

  • April 22, 2019

    Deals Rumor Mill: Dassault, Cerberus, Bain

    Dassault Systèmes is looking for stateside acquisitions, Cerberus Capital Management is looking to raise $2.5 billion with a new direct lending-focused fund and Bain Capital is looking at options for technology company Waystar.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals